-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $162

Benzinga·02/11/2026 17:49:19
Listen to the news
RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $176 to $162.